StageDead | Dead
Medalytix offers an automated screening system for detecting the early signs of diabetic eye disease (diabetic retinopathy). The solution delivers automated grading which is clinically validated and can be integrated with existing patient management systems through published interfaces.
Missing: Medalytix's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Medalytix's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Medalytix
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Medalytix is included in 1 Expert Collection, including Diabetes.
Latest Medalytix News
Apr 30, 2019
MEDALYTIX LIMITED Company status Nature of business (SIC) Previous company names FLEETNESS 579 LIMITED 22 Oct 2007 - 04 Apr 2008
Medalytix Frequently Asked Questions (FAQ)
Where is Medalytix's headquarters?
Medalytix's headquarters is located at Trinity Court, Manchester.
What is Medalytix's latest funding round?
Medalytix's latest funding round is Dead.
How much did Medalytix raise?
Medalytix raised a total of $2.87M.
Who are the investors of Medalytix?
Investors of Medalytix include Hotspur Capital Partners and Corporación Empresarial Emesa.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.